Data Presented At Scientific Meetings Can Have Impact On Patient Treatment
Study Recommends Longer Courses Of Chemotherapy For Bone Marrow Cancer
New Drugs Improve Outlook For Bone Marrow Cancer
HAI Delivery Extends Survival In Patients With Liver Metastasis
Two-Month Longer Survival Found With Gliadel Wafer
Unique Molecular Profile For Lung Cancer Described
U.S. Cigarette Sales Dropped 4.2 Percent Last Year
CT Finds Early Lung Tumors In Smokers, Former Smokers
Report Questions Effectiveness Of Bimanual Pelvic Exam
Breast Asymmetry Predicts Breast Cancer, Study Finds
FDA Approves Imaging System To Detect Cervical Pre-Cancer
NCI-Approved Clinical Trials
Trending Stories
- Vinay Prasad’s CV inaccurately claims past membership on the President’s Cancer Panel
- Breakthrough Therapy designation, ASCO plenary, and NEJM publication notwithstanding, breast cancer drug camizestrant gets a No from ODAC
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.” - CBER Director Vinay Prasad dared to “say no to drugs”
- J. Craig Venter’s work was foundational to cancer advancement of the past 25 years
- Prasad’s “deceit,” plus, ODAC’s tough decision against biomarker-based progression assessment (for now)









